戴春暉臨床副教授(Chun-Hwei Tai)

• Bouali-Benazzouz R, Tai CH, Chetrit J, Benazzouz A: Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus. Neuroscience 164:588-596, 2009

 

• Chen CY, Tai CH, Tsay W, Chen PY, Tien HF: Prediction of fatal intracranial hemorrhage in patients with acute myeloid leukemia. Ann Oncol 20:1100-1104, 2009

 

• Tai CH, Yen RF, Lin CH, Yen KY, Yip PK, Wu RM, et al: Focal brain glucose hypermetabolism in myoclonus-dystonia syndrome caused by an epsilon-sarcoglycan gene mutation. Parkinsonism Relat Disord 15:614-616, 2009

 

• Yu RL, Wu RM, Tai CH, Lin CH, Hua MS: Feeling-of-knowing in episodic memory in patients with Parkinson's disease with various motor symptoms. Movement disorders 25: 1034-1039, 2010

 

• Tai CH, Wu RM, Lin CH, Pan MK, Chen YF, Liu HM, et al: Deep brain stimulation therapy for parkinson's disease using frameless stereotaxy: comparison with frame-based surgery. European Journal of Neurology (Epub ahead of print on Apr. 23, 2010), 2010

 

• Huang,SL; Hsieh,CL; Wu,RM; Tai,CH; Lin,CH; Lu,WS . Minimal Detectable Change of   the Timed ""Up & Go"" Test and the Dynamic Gait Index in People With Parkinson  Disease. Pysical Therapy 2011  JAN;91 (1) :114-121

 

• Lin,CH; Chen,ML; Chen,GS; Tai,CH; Wu,RM. Novel variant Pro143Ala in HTRA2  contributes to Parkinson's disease by   inducing hyperphosphorylationof HTRA2 protein in  mitochondria. Human Genetics 2011 Dec;130 (6) :817-827

 

• Lin,CH; Wu,RM; Tai,CH; Chen,ML; Hu,FC . Lrrk2 S1647T and BDNF V66M interact with environmental factors to  increase risk of Parkinson's disease.Parkinsonism & Related Disorders,2011 Feb;17 (2) :84-88

 

• Tai,CH; Wu,RM; Liu,HM; Tsai,CW; Tseng,SH. Meige Syndrome Relieved by Bilateral  Pallidal Stimulation With Cycling Mode: Case Report. Neurosurgery 2011 Dec;69 (6) :E1333-E1337

 

• Tai,CH; Yang,YC; Pan,MK; Huang,CS; Kuo,CC. Modulation of subthalamic T-type Ca2+  channels remedies locomotor   deficits in a rat model of Parkinson disease. Journal of  Clinical Investigation 2011 Aug;121 (8) :3289-3305 

 

• Chen CY, Tai CH, Cheng A, Wu HC, Tsay W, Liu JH, Chen PY, Huang SY, Yao M, Tang JL, Tien HF. Intracranial hemorrhage in adult patients with hematological malignancies.. BMC Med. 2012 Aug 29;10:97.

 

• Yu RL, Wu RM, Tai CH, Lin CH, Cheng TW, Hua MS. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan.  Parkinsonism Relat Disord. 2012 Dec;18(10):1067-72.

 

• Hwu WL, Muramatsu S, Tseng SH, Tzen KY, Lee NC, Chien YH, Snyder RO, Byrne BJ, Tai CH, Wu RM. Gene therapy for aromatic L-amino acid decarboxylase deficiency.Sci Transl Med. 2012 May 16;4(134):134ra61.

 

• Wang SC, Lee LL, Wang WH, Sung HC, Chang HK, Hsu MY, Chang SC, Tai CH. Psychometric testing of the Chinese evidence-based practice scales. J Adv Nurs.2012 Nov;68(11):2570-7.

 

• Yang YC, Tai CH, Pan MK, Kuo CC. The T-type calcium channel as a new therapeutic target for Parkinson's disease. Pflugers Arch. 2014 Apr;466(4):747-55. doi: 10.1007/s00424-014-1466-6. Epub 2014 Feb 18. PubMed PMID:24531801.

 

• Lin CH, Chen ML, Lai TT, Tai CH, Wu RM. Mutational analysis of FBXO7 gene inParkinson's disease in a Taiwanese population. Neurobiol Aging. 2013Jun;34(6):1713.e1-4. doi: 10.1016/j.neurobiolaging.2012.12.023. Epub 2013 Jan 23.PubMed PMID: 23352116.

 

• Pan MK, Tai CH, Liu WC, Pei JC, Lai WS, Kuo CC. Deranged NMDAergic cortico-subthalamic transmission underlies parkinsonian motor deficits J Clin Invest. 2014 Oct;124(10):4629-41. doi: 10.1172/JCI75587. Epub 2014 Sep 9. PubMed PMID: 25202982; PubMed Central PMCID: PMC4191009.

 

• Yang YC, Tai CH, Pan MK, Kuo CC. The T-type calcium channel as a new therapeutic target for Parkinson's disease. Pflugers Arch. 2014 Apr;466(4):747-55. doi: 10.1007/s00424-014-1466-6. Epub 2014 Feb 18. Review PubMed PMID: 24531801.